"Frequency and relevance of viral reactivations in children under conventional chemotherapy".

"Frequency and relevance of viral reactivations in children under conventional chemotherapy". - VirusreaktChemo

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025188

Enrollment

200

Registered

2021-05-04

Start date

2020-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C91.00 C40.9

Interventions

Group 1: Measurement of PCR of Adeno/EBV/HHV6/HSM and CMV from EDTA blood, analysis of one change of titer

Eligibility

Sex/Gender

All

Age

0 Months to 18 Years

Inclusion criteria

Inclusion criteria: AML, ALL, lymphoma, Ewing's sarcoma, neuroblastoma, Consent of parents Therapy in Frankfurt or Münster

Exclusion criteria

Exclusion criteria: congenital immunodeficiancy

Design outcomes

Primary

Measure	Time frame
Percentage of reactivations of CMV, EBV, Adeno, HHV6, HSV under conventional chemotherapy	—

Secondary

Measure	Time frame
clinical correlation of virus reactivation (clinical symptoms, laboratory changes)	—

Countries

Germany

Contacts

Public ContactAnke Barnbrock

Klinik für Kinder- und Jugendmedizin

anke.barnbrock@kgu.de06963015017

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026